Hemic and Lymphatic Diseases: News and Research on Cytopenia

MeSH tree: C15.378.243

Elucidating a decades-old mystery of blood clotting

Why is it rare for dangerous blood clots to form in our blood? What happens if this safety mechanism fails? An international team of researchers involving the University of Greifswald has taken a major step toward finding ...

Serious infection risks linked to targeted cancer therapies

A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies. ...

FDA approves Inqovi for acute myeloid leukemia

The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older ...

page 1 from 11